Phase II Protocol for CLL With Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide
Clinical trial NCT01723839 · COMPLETED
Trial details
- NCT number
- NCT01723839
- Sponsor
- Hackensack Meridian Health
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-22
- Primary completion
- 2021-06-08
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.